Our partner Edesa Biotech announced positive Phase 2 Data for the licensed anti-TLR4 monoclonal antibody in hospitalized COVID-19 patients
A Swiss biotech success story award has been attributed to Novimmune at the recent Swiss Biotech days held in Basel.
"PARLONS ECONOMIE" - Is the future of medicine taking shape in Geneva?
Global collaboration with TG Therapeutic (NSDAQ: TGTX).
22nd program of "Le Monde de Demain" dedicated to biotechnologies.
